Results 191 to 200 of about 213,855 (329)
Molecular Characterization of Bacterial Virulence Factors and the Consequences for Vaccine Design The 1988 Fleming Lecture [PDF]
David Gordon
openalex +1 more source
Cathepsin B‐sensitive peptide–adjuvant conjugates are designed, synthesized, and evaluated to deliver an antigenic peptid and an adjuvant targeting Toll‐like receptors 7 and 8 (TLR7/8) to antigen presenting cells. The adjuvant is released by cathepsin B resulting in antigen presentation and TLR mediated T cell activation.
Marjolein M. E. Isendoorn +6 more
wiley +1 more source
Current challenges and improvements in assessing the immunogenicity of bacterial vaccines. [PDF]
Fantoni G +5 more
europepmc +1 more source
Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy. [PDF]
Cabral MP +6 more
europepmc +1 more source
Development of aChlamydia trachomatisbacterial ghost vaccine to fight human blindness
Francis O. Eko +1 more
openalex +2 more sources
Catalytic Amyloids: Turning Fibrils Into Biocatalysts
Amyloids, traditionally associated with diseases, have emerged as versatile catalytic scaffolds. From natural amyloid sequences to bioinspired and de novo designs, we highlight strategies to construct catalytic active sites and anchor enzymes onto fibrils, creating versatile nanomaterials with tunable activities. ABSTRACT Amyloids have been regarded as
Alessandra Esposito +3 more
wiley +1 more source
Immunological Insights and Therapeutic Advances in COPD: Exploring Oral Bacterial Vaccines for Immune Modulation and Clinical Improvement. [PDF]
Lewicki S +8 more
europepmc +1 more source
Construction of a full-length infectious bacterial artificial chromosome clone of duck enteritis virus vaccine strain [PDF]
Liu Chen +7 more
openalex +1 more source
ABSTRACT Colorectal cancer (CRC), as the second most common cause of cancer death worldwide, has seen a significant increase in its incidence rate in recent years. However, the current major clinical treatment methods, such as surgery, chemotherapy and radiotherapy, still have certain limitations and are difficult to achieve a complete cure.
Xiaoyu Song +3 more
wiley +1 more source
Mechanisms of resistance to cancer immunotherapy from a host–tumor interaction perspective. The central tumor cell is protected by multiple resistance mechanisms, including genetic mutations, epigenetic modifications, and metabolic alterations. The immunosuppressive tumor microenvironment features myeloid‐derived suppressor cells (MDSCs), regulatory T ...
Mohammed Elmujtba Adam Essa +2 more
wiley +1 more source

